State Ledger
Company profile

ALNYLAM PHARMACEUTICALS, INC. CIK 1178670

Ticker
ALNY (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, MA 02142
Fiscal year end
2025 (FY)
Market Data
Close
$227.05
Change
-$5.62
Change %
-2.42%
Volume
49,238

ALNY · trading date Oct 12, 2026 · previous close $232.67 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$3.71B
Net income
$313.75M
Total assets
$4.97B
Total liabilities
$4.18B
Stockholders' equity
$789.18M
Cash & equivalents
$1.66B
Operating income
$501.58M
Operating cash flow
$524.08M
Capital expenditures
$58.70M

Fiscal year 2025, via 10-K filed 2026-02-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
13.5%
Net margin
8.4%
Free cash flow
$465.38M
Free cash flow margin
12.5%
Liabilities / assets
84.1%
Equity / assets
15.9%
CapEx / revenue
1.6%
Operating cash flow / net income
1.67×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $3.71B $313.75M $4.97B $4.18B $789.18M
2024 $2.25B -$278.16M $4.24B $4.17B $67.09M
2023 $1.83B -$440.24M $3.83B $4.05B -$220.64M
2022 $1.04B -$1.13B $3.55B $3.70B -$158.22M
2021 $844.29M -$852.82M $3.64B $3.06B $588.20M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-07-30
Financials filed via
Form 10-K
filed 2026-02-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02142
675 WEST KENDALL STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies